Trials / Completed
CompletedNCT00442286
Rheos® Pivotal Trial
Rheos® Pivotal Trial: Rheos™ Baroreflex Hypertension Therapy System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 591 (actual)
- Sponsor
- CVRx, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to demonstrate the efficacy and safety of the Rheos system in subjects with hypertension that are resistant to treatment with at least three anti-hypertension agents, one of which is a diuretic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rheos® Baroreflex Hypertension System | Electrical activation of the Carotid Baroreflex |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2007-03-01
- Last updated
- 2017-03-20
- Results posted
- 2017-03-20
Locations
44 sites across 3 countries: United States, Germany, Netherlands
Source: ClinicalTrials.gov record NCT00442286. Inclusion in this directory is not an endorsement.